RCAN1 and early-onset autosomal dominant Alzheimer disease: Memantine has been approved for use in moderate to severe Alzheimer’s Disease (AD) [27] and interest in its possible use in DS originally stemmed from functional information on one Hsa21 encoded protein, regulator of calcineurin 1, RCAN1.